We found that CDKN1B, FAS, FOS, FOXO1, GABARAPL1, HDAC1, NFKB1, PEX3, PPP1R15A, and SIRT2 were all significantly lowly expressed in ovarian cancer than normal specimens (Figures 8A–J). Here, FOXO1 is linked to ovarian carcinoma.